These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31771951)

  • 1. The role of noncoding mutations in blood cancers.
    Rahman S; Mansour MR
    Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31771951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genome in a Three-Dimensional Context: Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer.
    Rovirosa L; Ramos-Morales A; Javierre BM
    Front Immunol; 2020; 11():592087. PubMed ID: 33117405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered TERT promoter and other genomic regulatory elements: occurrence and impact.
    Heidenreich B; Kumar R
    Int J Cancer; 2017 Sep; 141(5):867-876. PubMed ID: 28407294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies.
    Li K; Zhang Y; Liu X; Liu Y; Gu Z; Cao H; Dickerson KE; Chen M; Chen W; Shao Z; Ni M; Xu J
    Cancer Discov; 2020 May; 10(5):724-745. PubMed ID: 32188707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Noncoding Variants in Heritable Disease.
    French JD; Edwards SL
    Trends Genet; 2020 Nov; 36(11):880-891. PubMed ID: 32741549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.
    Cornish AJ; Hoang PH; Dobbins SE; Law PJ; Chubb D; Orlando G; Houlston RS
    Blood Adv; 2019 Jan; 3(1):21-32. PubMed ID: 30606723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-Enhancers Dysregulations in Hematological Malignancies.
    Belloucif Y; Lobry C
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional annotation of noncoding sequence variants.
    Ritchie GR; Dunham I; Zeggini E; Flicek P
    Nat Methods; 2014 Mar; 11(3):294-6. PubMed ID: 24487584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes.
    Cao X; Huber S; Ahari AJ; Traube FR; Seifert M; Oakes CC; Secheyko P; Vilov S; Scheller IF; Wagner N; Yépez VA; Blombery P; Haferlach T; Heinig M; Wachutka L; Hutter S; Gagneur J
    Genome Med; 2024 May; 16(1):70. PubMed ID: 38769532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood disease-causing and -suppressing transcriptional enhancers: general principles and
    Bresnick EH; Johnson KD
    Blood Adv; 2019 Jul; 3(13):2045-2056. PubMed ID: 31289032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.
    Zhou S; Treloar AE; Lupien M
    Cancer Discov; 2016 Nov; 6(11):1215-1229. PubMed ID: 27807102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.
    Diederichs S; Bartsch L; Berkmann JC; Fröse K; Heitmann J; Hoppe C; Iggena D; Jazmati D; Karschnia P; Linsenmeier M; Maulhardt T; Möhrmann L; Morstein J; Paffenholz SV; Röpenack P; Rückert T; Sandig L; Schell M; Steinmann A; Voss G; Wasmuth J; Weinberger ME; Wullenkord R
    EMBO Mol Med; 2016 May; 8(5):442-57. PubMed ID: 26992833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in transcriptional networks in cancer: the role of noncoding somatic driver mutations.
    Doane AS; Elemento O
    Curr Opin Genet Dev; 2022 Aug; 75():101919. PubMed ID: 35609422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.
    Lancho O; Herranz D
    Trends Cancer; 2018 Dec; 4(12):810-822. PubMed ID: 30470303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.
    Wang J; Dayem Ullah AZ; Chelala C
    Nucleic Acids Res; 2018 May; 46(8):e47. PubMed ID: 29390075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
    Scott LM; Rebel VI
    J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene variants in noncoding regions and their possible consequences.
    Wang GJ; Yang P; Xie HG
    Pharmacogenomics; 2006 Mar; 7(2):203-9. PubMed ID: 16515399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in the Untranslated Genome and Susceptibility to Infections.
    Ramsuran V; Ewy R; Nguyen H; Kulkarni S
    Front Immunol; 2018; 9():2046. PubMed ID: 30245696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
    Wang H; Li W; Guo R; Sun J; Cui J; Wang G; Hoffman AR; Hu JF
    Int J Cancer; 2014 Dec; 135(12):2783-94. PubMed ID: 24752773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory variation: an emerging vantage point for cancer biology.
    Li L; Lorzadeh A; Hirst M
    Wiley Interdiscip Rev Syst Biol Med; 2014; 6(1):37-59. PubMed ID: 24254976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.